Entry #14378: Gender-affirming care in Greece

Current Version

Region	Greece
Issue	Gender-affirming care
Status	Legal
Start Date	(unknown)
End Date	(none)
Description	Gender-affirming care is legal, albeit with significant structural, institutional and geographical barriers that impede equitable access. Although national health insurance (ΕΟΠΥΥ) covers hormone replacement therapy, accessing it still requires a formal psychiatric diagnosis of "transsexualism" or "gender dysphoria" and Greece has yet to effectively implement ICD-11 to depathologize trans identities. Furthermore, national health insurance excludes coverage for gender-affirming surgeries, forcing patients to bear the full financial burden of private care or seek treatment abroad. These challenges are exacerbated by systemic healthcare deficits, such as a lack of integrated, patient-centered care and the complete absence of transgender health from Greek medical curricula, which leaves healthcare professionals without adequate training. Compounding these issues are frequent supply chain delays and national inventory shortages of essential medications, such as estrogens pills, injectable testosterone and puberty blockers, alongside a total lack of integration within primary healthcare networks, which prevents local general practitioners from managing routine blood monitoring. Consequently, specialized public endocrinologists and psychiatric units remain almost exclusively concentrated in Athens, Thessaloniki, Patras and Herakleion, forcing individuals living in rural areas or on islands to bear significant financial travel burdens to receive essential care.
Sources	https://pmc.ncbi.nlm.nih.gov/articles/PMC10970254/ https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2026.1894638/full https://www.iasismed.eu/difficulties-on-transitioning-in-greece-a-personal-testimony-from-a-recipient-of-our-services/?lang=en

Revision History (4)

6 days ago

edited by Antotourou. Fixing wording to be better

Helpful?

0

	Old Value	New Value (Current)
Description	While gender-affirming care is legal, it faces significant structural, institutional and geographical barriers that impede equitable access. While national health insurance (ΕΟΠΥΥ) covers hormone replacement therapy, accessing it still requires a formal psychiatric diagnosis of "transsexualism" or "gender dysphoria" and Greece has yet to effectively implement ICD-11 to depathologize trans identities. Furthermore, national health insurance excludes coverage for gender-affirming surgeries, forcing patients to bear the full financial burden of private care or seek treatment abroad. These challenges are exacerbated by systemic healthcare deficits, such as a lack of integrated, patient-centered care and the complete absence of transgender health from Greek medical curricula, which leaves healthcare professionals without adequate training. Compounding these issues are frequent supply chain delays and national inventory shortages of essential medications, such as estrogens pills, injectable testosterone and puberty blockers, alongside a total lack of integration within primary healthcare networks, which prevents local general practitioners from managing routine blood monitoring. Consequently, specialized public endocrinologists and psychiatric units remain almost exclusively concentrated in Athens, Thessaloniki, Patras and Herakleion, forcing individuals living in rural areas or on islands to bear significant financial travel burdens to receive essential care.	Gender-affirming care is legal, albeit with significant structural, institutional and geographical barriers that impede equitable access. Although national health insurance (ΕΟΠΥΥ) covers hormone replacement therapy, accessing it still requires a formal psychiatric diagnosis of "transsexualism" or "gender dysphoria" and Greece has yet to effectively implement ICD-11 to depathologize trans identities. Furthermore, national health insurance excludes coverage for gender-affirming surgeries, forcing patients to bear the full financial burden of private care or seek treatment abroad. These challenges are exacerbated by systemic healthcare deficits, such as a lack of integrated, patient-centered care and the complete absence of transgender health from Greek medical curricula, which leaves healthcare professionals without adequate training. Compounding these issues are frequent supply chain delays and national inventory shortages of essential medications, such as estrogens pills, injectable testosterone and puberty blockers, alongside a total lack of integration within primary healthcare networks, which prevents local general practitioners from managing routine blood monitoring. Consequently, specialized public endocrinologists and psychiatric units remain almost exclusively concentrated in Athens, Thessaloniki, Patras and Herakleion, forcing individuals living in rural areas or on islands to bear significant financial travel burdens to receive essential care.
Description	Show Difference While gender-affirming care is legal, it faces significant structural, institutional and geographical barriers that impede equitable access. While national health insurance (ΕΟΠΥΥ) covers hormone replacement therapy, accessing it still requires a formal psychiatric diagnosis of "transsexualism" or "gender dysphoria" and Greece has yet to effectively implement ICD-11 to depathologize trans identities. Furthermore, national health insurance excludes coverage for gender-affirming surgeries, forcing patients to bear the full financial burden of private care or seek treatment abroad. These challenges are exacerbated by systemic healthcare deficits, such as a lack of integrated, patient-centered care and the complete absence of transgender health from Greek medical curricula, which leaves healthcare professionals without adequate training. Compounding these issues are frequent supply chain delays and national inventory shortages of essential medications, such as estrogens pills, injectable testosterone and puberty blockers, alongside a total lack of integration within primary healthcare networks, which prevents local general practitioners from managing routine blood monitoring. Consequently, specialized public endocrinologists and psychiatric units remain almost exclusively concentrated in Athens, Thessaloniki, Patras and Herakleion, forcing individuals living in rural areas or on islands to bear significant financial travel burdens to receive essential care. Gender-affirming care is legal, albeit with significant structural, institutional and geographical barriers that impede equitable access. Although national health insurance (ΕΟΠΥΥ) covers hormone replacement therapy, accessing it still requires a formal psychiatric diagnosis of "transsexualism" or "gender dysphoria" and Greece has yet to effectively implement ICD-11 to depathologize trans identities. Furthermore, national health insurance excludes coverage for gender-affirming surgeries, forcing patients to bear the full financial burden of private care or seek treatment abroad. These challenges are exacerbated by systemic healthcare deficits, such as a lack of integrated, patient-centered care and the complete absence of transgender health from Greek medical curricula, which leaves healthcare professionals without adequate training. Compounding these issues are frequent supply chain delays and national inventory shortages of essential medications, such as estrogens pills, injectable testosterone and puberty blockers, alongside a total lack of integration within primary healthcare networks, which prevents local general practitioners from managing routine blood monitoring. Consequently, specialized public endocrinologists and psychiatric units remain almost exclusively concentrated in Athens, Thessaloniki, Patras and Herakleion, forcing individuals living in rural areas or on islands to bear significant financial travel burdens to receive essential care.

6 days ago

edited by Antotourou. Fixing wording of description

Helpful?

0

	Old Value	New Value
Description	Gender-affirming care in Greece faces significant structural, institutional and geographical barriers that impede equitable access. While national health insurance (ΕΟΠΥΥ) covers hormone replacement therapy, accessing it still requires a formal psychiatric diagnosis of "transsexualism" or "gender dysphoria" and Greece has yet to effectively implement ICD-11 to depathologize trans identities. Furthermore, national health insurance excludes coverage for gender-affirming surgeries, forcing patients to bear the full financial burden of private care or seek treatment abroad. These challenges are exacerbated by systemic healthcare deficits, such as a lack of integrated, patient-centered care and the complete absence of transgender health from Greek medical curricula, which leaves healthcare professionals without adequate training. Compounding these issues are frequent supply chain delays and national inventory shortages of essential medications, such as estrogens pills, injectable testosterone and puberty blockers, alongside a total lack of integration within primary healthcare networks, which prevents local general practitioners from managing routine blood monitoring. Consequently, specialized public endocrinologists and psychiatric units remain almost exclusively concentrated in Athens, Thessaloniki, Patras and Herakleion, forcing trans individuals living in rural areas or on islands to bear significant financial and logistical travel burdens to receive essential care.	While gender-affirming care is legal, it faces significant structural, institutional and geographical barriers that impede equitable access. While national health insurance (ΕΟΠΥΥ) covers hormone replacement therapy, accessing it still requires a formal psychiatric diagnosis of "transsexualism" or "gender dysphoria" and Greece has yet to effectively implement ICD-11 to depathologize trans identities. Furthermore, national health insurance excludes coverage for gender-affirming surgeries, forcing patients to bear the full financial burden of private care or seek treatment abroad. These challenges are exacerbated by systemic healthcare deficits, such as a lack of integrated, patient-centered care and the complete absence of transgender health from Greek medical curricula, which leaves healthcare professionals without adequate training. Compounding these issues are frequent supply chain delays and national inventory shortages of essential medications, such as estrogens pills, injectable testosterone and puberty blockers, alongside a total lack of integration within primary healthcare networks, which prevents local general practitioners from managing routine blood monitoring. Consequently, specialized public endocrinologists and psychiatric units remain almost exclusively concentrated in Athens, Thessaloniki, Patras and Herakleion, forcing individuals living in rural areas or on islands to bear significant financial travel burdens to receive essential care.
Description	Show Difference Gender-affirming care in Greece faces significant structural, institutional and geographical barriers that impede equitable access. While national health insurance (ΕΟΠΥΥ) covers hormone replacement therapy, accessing it still requires a formal psychiatric diagnosis of "transsexualism" or "gender dysphoria" and Greece has yet to effectively implement ICD-11 to depathologize trans identities. Furthermore, national health insurance excludes coverage for gender-affirming surgeries, forcing patients to bear the full financial burden of private care or seek treatment abroad. These challenges are exacerbated by systemic healthcare deficits, such as a lack of integrated, patient-centered care and the complete absence of transgender health from Greek medical curricula, which leaves healthcare professionals without adequate training. Compounding these issues are frequent supply chain delays and national inventory shortages of essential medications, such as estrogens pills, injectable testosterone and puberty blockers, alongside a total lack of integration within primary healthcare networks, which prevents local general practitioners from managing routine blood monitoring. Consequently, specialized public endocrinologists and psychiatric units remain almost exclusively concentrated in Athens, Thessaloniki, Patras and Herakleion, forcing trans individuals living in rural areas or on islands to bear significant financial and logistical travel burdens to receive essential care. is legal, it faces significant structural, institutional and geographical barriers that impede equitable access. While national health insurance (ΕΟΠΥΥ) covers hormone replacement therapy, accessing it still requires a formal psychiatric diagnosis of "transsexualism" or "gender dysphoria" and Greece has yet to effectively implement ICD-11 to depathologize trans identities. Furthermore, national health insurance excludes coverage for gender-affirming surgeries, forcing patients to bear the full financial burden of private care or seek treatment abroad. These challenges are exacerbated by systemic healthcare deficits, such as a lack of integrated, patient-centered care and the complete absence of transgender health from Greek medical curricula, which leaves healthcare professionals without adequate training. Compounding these issues are frequent supply chain delays and national inventory shortages of essential medications, such as estrogens pills, injectable testosterone and puberty blockers, alongside a total lack of integration within primary healthcare networks, which prevents local general practitioners from managing routine blood monitoring. Consequently, specialized public endocrinologists and psychiatric units remain almost exclusively concentrated in Athens, Thessaloniki, Patras and Herakleion, forcing individuals living in rural areas or on islands to bear significant financial travel burdens to receive essential care.

6 days ago

edited by Antotourou. Added lots of info

Helpful?

0

	Old Value (Original)	New Value
Description	In Greece, the largest restrictions to accessing gender-affirming care are practical due to low availability and high prices. No explicit legal barriers exist.	Gender-affirming care in Greece faces significant structural, institutional and geographical barriers that impede equitable access. While national health insurance (ΕΟΠΥΥ) covers hormone replacement therapy, accessing it still requires a formal psychiatric diagnosis of "transsexualism" or "gender dysphoria" and Greece has yet to effectively implement ICD-11 to depathologize trans identities. Furthermore, national health insurance excludes coverage for gender-affirming surgeries, forcing patients to bear the full financial burden of private care or seek treatment abroad. These challenges are exacerbated by systemic healthcare deficits, such as a lack of integrated, patient-centered care and the complete absence of transgender health from Greek medical curricula, which leaves healthcare professionals without adequate training. Compounding these issues are frequent supply chain delays and national inventory shortages of essential medications, such as estrogens pills, injectable testosterone and puberty blockers, alongside a total lack of integration within primary healthcare networks, which prevents local general practitioners from managing routine blood monitoring. Consequently, specialized public endocrinologists and psychiatric units remain almost exclusively concentrated in Athens, Thessaloniki, Patras and Herakleion, forcing trans individuals living in rural areas or on islands to bear significant financial and logistical travel burdens to receive essential care.
Description	Show Difference In Greece, the largest restrictions to accessing gender-affirming care are practical due to low availability and high prices. No explicit legal barriers exist. Gender-affirming care in Greece faces significant structural, institutional and geographical barriers that impede equitable access. While national health insurance (ΕΟΠΥΥ) covers hormone replacement therapy, accessing it still requires a formal psychiatric diagnosis of "transsexualism" or "gender dysphoria" and Greece has yet to effectively implement ICD-11 to depathologize trans identities. Furthermore, national health insurance excludes coverage for gender-affirming surgeries, forcing patients to bear the full financial burden of private care or seek treatment abroad. These challenges are exacerbated by systemic healthcare deficits, such as a lack of integrated, patient-centered care and the complete absence of transgender health from Greek medical curricula, which leaves healthcare professionals without adequate training. Compounding these issues are frequent supply chain delays and national inventory shortages of essential medications, such as estrogens pills, injectable testosterone and puberty blockers, alongside a total lack of integration within primary healthcare networks, which prevents local general practitioners from managing routine blood monitoring. Consequently, specialized public endocrinologists and psychiatric units remain almost exclusively concentrated in Athens, Thessaloniki, Patras and Herakleion, forcing trans individuals living in rural areas or on islands to bear significant financial and logistical travel burdens to receive essential care.
Sources	https://pmc.ncbi.nlm.nih.gov/articles/PMC10970254/	https://pmc.ncbi.nlm.nih.gov/articles/PMC10970254/ https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2026.1894638/full https://www.iasismed.eu/difficulties-on-transitioning-in-greece-a-personal-testimony-from-a-recipient-of-our-services/?lang=en
Sources	Show Difference https://pmc.ncbi.nlm.nih.gov/articles/PMC10970254/ https://pmc.ncbi.nlm.nih.gov/articles/PMC10970254/ https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2026.1894638/full https://www.iasismed.eu/difficulties-on-transitioning-in-greece-a-personal-testimony-from-a-recipient-of-our-services/?lang=en

Feb 15, 2025

created by jadeywadey

Helpful?

0

	Original entry
Status	Legal
Start Date	(unknown)
End Date	(none)
Description	In Greece, the largest restrictions to accessing gender-affirming care are practical due to low availability and high prices. No explicit legal barriers exist.
Sources	https://pmc.ncbi.nlm.nih.gov/articles/PMC10970254/